相关实验视频

Updated: Jul 18, 2025

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

慢性骨髓单细胞白血病中白血病转变的表型亚型

Guillermo Montalban-Bravo¹, Rashmi Kanagal-Shamanna², Ziyi Li³

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

British journal of haematology

|August 23, 2023

概括

慢性骨髓单细胞白血病 (CMML) 通过不同的单细胞或不成熟的骨髓单细胞路径发展为急性骨髓单细胞白血病 (AML). 了解这些CMML进展模式有助于开发针对AML的向疗法.

科学领域:

血液学血液学血液学
在瘤学瘤学.
基因组学就是基因组学.

背景情况:

慢性骨髓单细胞白血病 (CMML) 是一种白血病前的疾病,具有转化为急性骨髓性白血病 (AML) 的显著风险.
描述CMML进展的不同途径对于理解白血病发生和开发有效的治疗策略至关重要.

研究的目的:

研究与CMML转化为AML相关的表型和基因组模式.
确定CMML进展的不同轨迹及其潜在的遗传驱动因素.

主要方法:

对189名AML患者队列的分析,该队列从CMML演变为AML.
评估表型特征 (细胞表面标记物表达) 和基因组资料 (突变分析).
基于进展轨迹的AML亚型的分类:单细胞性 (Mo-AML),不成熟的骨髓性 (My-AML) 和红细胞性 (Ery-AML).

主要成果:

转化为AML的CMML遵循不同的单细胞 (53%),不成熟的髓状细胞 (43%),或红细胞 (2%) 的轨迹.
莫-AML的特征是特定的单细胞/单细胞标记物和共同主导的SRSF2,TET2和RAS路径突变.
我的AML表现出不成熟的骨髓细胞爆炸特征,具有更高的CEBPA突变频率和更少的SRSF2-TET2或RAS通路共变.
埃里-AML与复杂的型和TP53突变有关.
在My-AML中观察到改善整体存活率 (OS) 和无事件存活率 (EFS) 的趋势,但在My-AML中观察到低甲基化剂-venetoclax组合,而不是Mo-AML.

结论:

从CMML发展为AML不是单一的事件,而是通过可识别的表型和基因组途径发生.
这些不同的进展途径,特别是Mo-AML和My-AML,具有不同的遗传基础,并且可能对治疗有不同的反应.
这些发现为CMML进展为AML的表型特异性治疗策略提供了基础.

关键词:

在CMMLML中,CMML是CMML.基因型基因型基因型一个单细胞的单细胞细胞.骨髓化物骨髓化物现象型现象型是一种现象型.转化转化转化转化转化转化转化转化

更多相关视频

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

Classification of Leukocytes

Classification of Leukocytes

Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...